Compare Abbott India with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs AUROBINDO PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA AUROBINDO PHARMA ABBOTT INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 48.1 10.9 440.5% View Chart
P/BV x 13.8 2.4 580.7% View Chart
Dividend Yield % 0.5 0.5 94.9%  

Financials

 ABBOTT INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
AUROBINDO PHARMA
Mar-18
ABBOTT INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs6,110809 755.3%   
Low Rs3,996504 792.9%   
Sales per share (Unadj.) Rs1,552.2281.1 552.3%  
Earnings per share (Unadj.) Rs188.841.4 456.5%  
Cash flow per share (Unadj.) Rs196.450.9 386.1%  
Dividends per share (Unadj.) Rs55.002.50 2,200.0%  
Dividend yield (eoy) %1.10.4 285.8%  
Book value per share (Unadj.) Rs796.6199.4 399.6%  
Shares outstanding (eoy) m21.25585.88 3.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.3 139.4%   
Avg P/E ratio x26.815.9 168.6%  
P/CF ratio (eoy) x25.712.9 199.4%  
Price / Book Value ratio x6.33.3 192.6%  
Dividend payout %29.16.0 481.9%   
Avg Mkt Cap Rs m107,376384,630 27.9%   
No. of employees `0003.317.3 19.2%   
Total wages/salary Rs m3,93721,308 18.5%   
Avg. sales/employee Rs Th9,929.39,500.7 104.5%   
Avg. wages/employee Rs Th1,185.11,229.4 96.4%   
Avg. net profit/employee Rs Th1,207.71,397.9 86.4%   
INCOME DATA
Net Sales Rs m32,985164,666 20.0%  
Other income Rs m1,1701,020 114.7%   
Total revenues Rs m34,155165,686 20.6%   
Gross profit Rs m5,24537,718 13.9%  
Depreciation Rs m1625,580 2.9%   
Interest Rs m38777 4.9%   
Profit before tax Rs m6,21532,380 19.2%   
Minority Interest Rs m031 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2038,183 26.9%   
Profit after tax Rs m4,01224,229 16.6%  
Gross profit margin %15.922.9 69.4%  
Effective tax rate %35.425.3 140.3%   
Net profit margin %12.214.7 82.7%  
BALANCE SHEET DATA
Current assets Rs m22,655121,878 18.6%   
Current liabilities Rs m6,68186,806 7.7%   
Net working cap to sales %48.421.3 227.4%  
Current ratio x3.41.4 241.5%  
Inventory Days Days65130 49.9%  
Debtors Days Days2968 42.6%  
Net fixed assets Rs m83581,037 1.0%   
Share capital Rs m213586 36.3%   
"Free" reserves Rs m16,715116,218 14.4%   
Net worth Rs m16,928116,804 14.5%   
Long term debt Rs m04,512 0.0%   
Total assets Rs m24,162211,052 11.4%  
Interest coverage x163.742.7 383.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.8 175.0%   
Return on assets %16.811.8 141.5%  
Return on equity %23.720.7 114.3%  
Return on capital %36.927.4 135.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36980,727 0.5%   
Fx outflow Rs m3,80734,700 11.0%   
Net fx Rs m-3,43846,027 -7.5%   
CASH FLOW
From Operations Rs m1,52719,548 7.8%  
From Investments Rs m-2,148-19,570 11.0%  
From Financial Activity Rs m-1,0248,642 -11.9%  
Net Cashflow Rs m-1,6468,922 -18.4%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 8.0 99.4%  
FIIs % 0.1 27.7 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.2 167.6%  
Shareholders   18,270 69,601 26.2%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Telecom and Automobiles Stocks Lose(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.1% while the Hang Seng is down 0.1%.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Oct 18, 2019 09:55 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS